<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Congenital pulmonary airway malformation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Congenital pulmonary airway malformation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Congenital pulmonary airway malformation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher M Oermann, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph A Garcia-Prats, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gregory Redding, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 03, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Congenital pulmonary airway malformation (CPAM), previously known as congenital cystic adenomatoid malformation (CCAM), is a rare developmental anomaly of the lower respiratory tract [<a href="#rid1">1,2</a>]. Affected patients may present with respiratory distress in the newborn period or may remain asymptomatic until later in life. Many cases are now detected by routine prenatal ultrasound examination. Surgical resection is the definitive treatment.</p><p>The clinical presentation and postnatal management of CPAM are discussed below. Prenatal diagnosis, course, and management of CPAM are discussed in a separate topic review. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Congenital pulmonary airway malformation (CPAM) is a developmental malformation of the lower respiratory tract. Although rare, it is the most common congenital lung lesion. The widespread use of antenatal ultrasound examination has resulted in an increase in the prenatal diagnosis of CPAM [<a href="#rid3">3,4</a>]. Data from large population registries suggest an incidence of congenital lung cysts in the range of 1 per 8300 to 35,000 live births [<a href="#rid5">5,6</a>]. Large-cyst subtypes account for approximately 70 percent of CPAMs, or 2 to 8 per 100,000 live births.</p><p>CPAMs occur sporadically. Their formation is not related to maternal factors such as race, age, or exposures. In some series, lesions that present in infancy have a slight male preponderance [<a href="#rid7">7-10</a>], although others found no sex predilection [<a href="#rid11">11,12</a>]. There is no known genetic predisposition, with the exception of type 4 malformations, which have been associated with a familial pleuropulmonary blastoma (PPB) syndrome. (See <a class="local">'Pleuropulmonary blastoma'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Congenital pulmonary airway malformations (CPAMs) result from abnormalities of branching morphogenesis of the lung. The different types of CPAMs are thought to originate at different levels of the tracheobronchial tree and at different stages of lung development, possibly influenced by in utero airway obstruction and/or atresia [<a href="#rid5">5,13,14</a>]. (See <a class="local">'Pathology'</a> below.)</p><p>The molecular mechanisms resulting in CPAM formation remain largely unknown but may include an imbalance between cell proliferation and apoptosis during organogenesis [<a href="#rid15">15-18</a>]. Disorders of the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F142960&amp;token=tEpDslnpc0F0kICl%2Fz7sFYR8Q1aXDxBReNYTLBTBwCSteMYy6afiROkjT7JSD1uA&amp;TOPIC_ID=6346" target="_blank"><i>HOXB5</i></a> gene have been implicated in this process [<a href="#rid19">19</a>]. One study found that CPAMs resected from fetuses and newborns had twice as much cell proliferation and five times the number of apoptotic bodies as did normal fetal and neonatal lung tissue [<a href="#rid15">15</a>]. Advances in the development of transgenic/knockout animal models and the widespread use of next-generation genetic sequencing on surgical tissue specimens have led to a much more robust, though incomplete, understanding of the molecular mechanisms involved in the development of CPAM [<a href="#rid20">20</a>].</p><p>This process may be mediated in part by glial cell-derived neurotrophic factor (GDNF), a growth factor that is widely expressed in organs with development characterized by epithelial-mesenchymal interaction. In one report, GDNF was detected in epithelial and endothelial cells from normal fetal lung and in epithelial cells from CPAMs, while none was found in normal lung tissue obtained from older infants and children (four months to three years of age) [<a href="#rid16">16</a>]. Vascularity was also reduced in CPAMs compared with normal lung tissue [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H4"><span class="h1">PATHOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histopathology</strong> – Congenital pulmonary airway malformations (CPAMs) are hamartomatous lesions that are comprised of cystic and adenomatous elements arising from tracheal, bronchial, bronchiolar, or alveolar tissue. Large lesions can compromise alveolar growth and development by compressing adjacent normal tissue.</p><p></p><p class="bulletIndent1">CPAMs have connections with the tracheobronchial tree, although the connecting bronchi usually are not normal. The arterial supply and venous drainage from the lesion are almost always from the pulmonary circulation, though vascular connections to the systemic circulation have been reported.</p><p></p><p class="bulletIndent1">CPAMs are equally distributed between the right and left lungs and can arise in all lobes. Lesions are usually limited to one lobe, but infrequently, they can involve multiple lobes [<a href="#rid7">7,9,10</a>]. The CPAMs that present during adulthood tend to be in the lower lobes [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Types</strong> – CPAMs were previously known as congenital cystic adenomatoid malformations (CCAMs) which were divided into three major types based upon the size of the cysts and their cellular characteristics (predominantly bronchial, bronchiolar, or bronchiolar/alveolar duct cells) [<a href="#rid22">22-24</a>]. Under this classification scheme, more than 65 percent of CPAMs were type 1, while type 2 comprised 20 to 25 percent and type 3 comprised 8 percent [<a href="#rid22">22,23</a>].</p><p></p><p class="bulletIndent1">In the present classification scheme, these congenital cystic lung lesions are now called CPAM, and two additional types (0 and 4) were added. Type 0 arises from the trachea, and type 4 lesions have alveolar/distal acinar origins [<a href="#rid25">25-27</a>].</p><p></p><p class="bulletIndent1">Each type of CPAM has distinct pathologic characteristics [<a href="#rid24">24-27</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Type 0</strong> – Type 0 is the rarest form, comprising only 1 to 3 percent of cases, and originates from tracheal or bronchial tissue. The cysts are small, with a maximum diameter of 0.5 cm, and are lined with ciliated pseudostratified epithelium [<a href="#rid27">27</a>]. Mucus cells and cartilage are present, but skeletal muscle is absent. This is a diffuse malformation that involves the entire lung. Gas exchange is severely impaired, and affected infants die at birth [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Type 1</strong> – Type 1 is the most common form of CPAM, comprising 60 to 70 percent [<a href="#rid5">5</a>]. This type is thought to originate from the distal bronchi or proximal bronchioles. Because there is well-differentiated tissue within the lesions, this type probably originates relatively late during embryogenesis (7 to 10 weeks).</p><p></p><p class="bulletIndent2">Type 1 lesions are comprised of distinct thin-walled cysts 2 to 10 cm in diameter  (<a class="graphic graphic_picture graphicRef69459" href="/d/graphic/69459.html" rel="external">picture 1</a>). The cysts are usually single but may be multiloculated. They are lined with ciliated pseudostratified columnar epithelium  (<a class="graphic graphic_picture graphicRef82204" href="/d/graphic/82204.html" rel="external">picture 2</a>), and the walls contain smooth muscle and elastic tissue. Mucus-producing cells are present in approximately one-third of cases, and a thin fibromuscular layer may be present under the epithelium. Small islands of abnormal cartilage are found in 5 to 10 percent of lesions. The adjacent alveoli are relatively normal, and in 95 percent of cases, only one lobe of the lung is involved [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent2">This type of CPAM has malignant potential, but the magnitude of the risk is not well delineated. Care must be taken not to misclassify type 4 lesions as type 1, because type 4 lesions have a high malignant potential. (See <a class="local">'Association with malignancy'</a> below.)</p><p></p><p class="bulletIndent2">The clinical presentation of type 1 CPAMs depends primarily on the size of the cysts. Large cysts may be detected on prenatal ultrasound. If they compress adjacent normal lung, they can cause respiratory distress in the neonate, mediastinal shift to the contralateral side, and flattening of the ipsilateral diaphragm. Smaller cysts may present months or years after birth as incidental lesions or a focus of infection.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Type 2</strong> – Type 2 lesions comprise 15 to 20 percent of CPAMs. They consist of multiple cysts 0.5 to 2 cm in diameter and solid areas that blend into adjacent normal tissue  (<a class="graphic graphic_picture graphicRef54211" href="/d/graphic/54211.html" rel="external">picture 3</a>). The cysts resemble dilated terminal bronchioles and are lined with ciliated cuboidal or columnar epithelium  (<a class="graphic graphic_picture graphicRef66962" href="/d/graphic/66962.html" rel="external">picture 4</a>). Type 2 lesions may also have a thin fibromuscular layer with an increase in elastic tissue. Mucus-secreting cells and cartilage are absent. There is usually little mass effect on the adjacent lung. Extralobar pulmonary sequestrations may have a similar appearance, but unlike type 2 CPAM, these have a systemic blood supply. Hybrid forms, with features of both type 2 CPAM and extralobar pulmonary sequestrations, have been described [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/6341.html" rel="external">"Bronchopulmonary sequestration"</a>.)</p><p></p><p class="bulletIndent2">Other congenital anomalies are observed in patients with type 2 CPAM in up to 60 percent of cases [<a href="#rid5">5,28</a>]. These malformations include esophageal atresia with tracheoesophageal fistula [<a href="#rid29">29</a>]; bilateral renal agenesis or dysgenesis [<a href="#rid30">30</a>]; intestinal atresia; other pulmonary malformations; and diaphragmatic, cardiac, central nervous system, and bony anomalies. This association with other congenital malformations suggests that insults resulting in type 2 CPAMs occur during the third week of gestation. In many cases, the associated anomalies are the presenting feature and the CPAM is detected as a secondary finding. Type 2 CPAMs are not at risk for development of malignancy.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Type 3</strong> – Type 3 CPAMs comprise 5 to 10 percent of CPAMs. They are often very large and can involve an entire lobe or several lobes. They have an acinar origin and consist of adenomatoid proliferation of distal airways or airspaces. They can be a mixture of cystic and solid tissue or be entirely solid. Because of their large size and lack of differentiation, type 3 CPAMs are thought to originate early in gestation (26 to 28 days). The numerous small cysts are less than 0.5 cm in diameter and are lined with nonciliated cuboidal epithelium. They have a thin fibromuscular layer and increased elastic tissue, similar to type 2 lesions. Mucus-secreting cells and cartilage are absent.</p><p></p><p class="bulletIndent2">Affected infants present in utero or at birth, usually with severe respiratory distress or death in the neonatal period [<a href="#rid5">5</a>]. This type of CPAM has not been associated with malignancy.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Type 4</strong> – Type 4 lesions comprise 5 to 10 percent of CPAMs [<a href="#rid5">5,27,31</a>]. The cysts have a maximum diameter of 7 cm and consist of nonciliated, flattened, alveolar lining cells, with no mucus cells or skeletal muscle.</p><p></p><p class="bulletIndent2">Type 4 CPAMs may present at birth or in childhood, often with tension pneumothorax or infection, but they may also be identified as incidental findings in asymptomatic patients. Importantly, this type of CPAM is strongly associated with malignancy, especially with pleuropulmonary blastoma (PPB). (See <a class="local">'Association with malignancy'</a> below.)</p><p></p><p class="headingAnchor" id="H11"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>The presentation of congenital pulmonary airway malformation (CPAM) is variable. Many are identified by routine prenatal ultrasound examination. Early reviews indicated that up to two-thirds of infants with prenatally diagnosed CPAM are symptomatic at birth [<a href="#rid12">12</a>]. More recent references suggest that only approximately 25 percent of affected newborns are symptomatic [<a href="#rid2">2,32</a>]. This discrepancy may reflect improvements in prenatal ultrasound technology, such that smaller lesions are now identified, and these tend to be asymptomatic.</p><p class="headingAnchor" id="H12"><span class="h2">Prenatal presentation</span><span class="headingEndMark"> — </span>The appearance of CPAMs on prenatal ultrasound ranges from incidental findings of cystic-appearing lesions to massive pulmonary involvement [<a href="#rid3">3,7,33-35</a>]. Lesions regress and appear to resolve during the course of gestation in approximately 50 percent of cases as determined by fetal ultrasonography [<a href="#rid36">36</a>], but most of these will still be detectable on postnatal imaging [<a href="#rid37">37</a>]. Among lesions present at birth, complete spontaneous resolution in the postnatal period has been reported in a small number of cases [<a href="#rid38">38,39</a>]. A retrospective review suggested that peak CPAM size occurred at approximately 25 weeks gestational age and that regression in size led to favorable outcomes unless severe hydrops was present [<a href="#rid40">40</a>]. Prenatal diagnosis, course, and management of CPAM are discussed in a separate topic review. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management"</a>.)</p><p class="headingAnchor" id="H116169333"><span class="h3">Prenatal imaging</span><span class="headingEndMark"> — </span>CPAM is one of the most common lung lesions diagnosed prenatally, although the birth prevalence is quite low. Prenatal diagnosis is typically made by ultrasonography  (<a class="graphic graphic_diagnosticimage graphicRef55315 graphicRef63885" href="/d/graphic/55315.html" rel="external">image 1A-B</a> and <a class="graphic graphic_diagnosticimage graphicRef81883" href="/d/graphic/81883.html" rel="external">image 2</a>). CPAMs presenting prenatally are classified by their ultrasound findings and gross anatomy [<a href="#rid41">41,42</a>]. Microcystic lesions consist of cysts &lt;5 mm in diameter and appear echogenic and solid, while macrocystic lesions contain one or more cysts &gt;5 mm in diameter. The CPAM volume ratio (CVR) is an index of CPAM volume referenced to the fetal head  (<a class="graphic graphic_diagnosticimage graphicRef55315 graphicRef63885" href="/d/graphic/55315.html" rel="external">image 1A-B</a>) and is a useful prognostic indicator [<a href="#rid2">2,38,43</a>]. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Prenatal diagnosis'</a>.)</p><p>Additional evaluation with prenatal magnetic resonance imaging (MRI) is useful for distinguishing CPAM from other pulmonary anomalies, including bronchopulmonary sequestration (BPS), congenital diaphragmatic hernia, and congenital lobar emphysema.</p><p>Approximately 25 percent of infants with CPAM detected prenatally also have other structural anomalies; most of these cases are associated with type 2 CPAM [<a href="#rid44">44</a>]. In patients with such anomalies, a fetal karyotype should be obtained. Isolated CPAMs typically are not associated with chromosomal abnormalities.</p><p class="headingAnchor" id="H13"><span class="h3">Development of hydrops</span><span class="headingEndMark"> — </span>Fetal hydrops develops in 5 to 40 percent of cases due to hemodynamic alterations from vena cava obstruction and cardiac displacement and compression [<a href="#rid2">2,36,43</a>]. The risk of hydrops is highest in fetuses with large lesions, lesions that persist into the third trimester, and microcystic lesions. In particular, the CVR, which is a measure of CPAM volume referenced to the fetal head, predicts an increased risk of hydrops. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Hydrops with abnormal fetal echocardiography'</a>.)</p><p class="headingAnchor" id="H116170175"><span class="h2">Neonatal period</span></p><p class="headingAnchor" id="H1151154728"><span class="h3">Asymptomatic</span><span class="headingEndMark"> — </span>Approximately three-quarters of patients with a prenatal diagnosis of CPAM are asymptomatic at birth [<a href="#rid32">32,38,45,46</a>].</p><p>The natural history of CPAMs that are asymptomatic at birth is not well described. It is clear that some of these infants will develop complications (primarily infection) during the first few years of life, but the frequency varies markedly among different case series. The risk of malignancy is extremely low, except in type 4 CPAMs, although type 1 lesions may also have some malignant potential. The uncertainty about the risk of infection and malignancy is the basis for controversy about how to manage these patients, as discussed below. (See <a class="local">'Complications'</a> below and <a class="local">'Asymptomatic patients'</a> below.)</p><p class="headingAnchor" id="H1151154739"><span class="h3">Symptomatic</span><span class="headingEndMark"> — </span>The remaining 25 percent of patients with a prenatal diagnosis of CPAM are symptomatic at birth [<a href="#rid38">38,45,46</a>]. As an example, in a series of 89 infants with prenatally diagnosed CPAM, 22 had abnormal breathing, including 12 with severe respiratory distress [<a href="#rid45">45</a>]. The likelihood of respiratory distress, and its severity, increases with the size of the lesion (eg, CVR &gt;0.84) [<a href="#rid45">45</a>]. Other sonographic predictors of respiratory distress at birth include mediastinal shift, polyhydramnios, and ascites.</p><p>Some clinical features are associated with CPAM type:</p><p class="bulletIndent1"><span class="glyph">●</span>Type 0 CPAMs are associated with severely impaired gas exchange, and affected infants die at birth [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 1 CPAMs comprise the majority of CPAMs presenting in newborns. When symptomatic, typical signs include tachypnea, increased respiratory effort with grunting and retractions, and cyanosis. Depending upon the extent of air trapping, large cysts may expand, which leads to respiratory distress.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 2 CPAMs are often diagnosed soon after birth because of their association with other congenital anomalies, which are present in up to 60 percent of affected patients. Presenting respiratory signs and symptoms are similar to those noted with type 1 CPAMs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 3 CPAM is the most severe form (other than type 0, which is uniformly lethal at birth). Type 3 lesions are large and can involve the entire lung, and fetal hydrops and pulmonary hypoplasia are typical. Infants may be stillborn or present immediately after birth with severe, progressive respiratory distress, cyanosis, and respiratory failure. Historically, there has been a strong male predominance [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Type 4 CPAMs can present in the neonatal period and may be difficult to distinguish from type 1 lesions. Presentation with spontaneous pneumothorax has been reported in several cases [<a href="#rid5">5,47</a>]. Because many type 4 lesions are probably due to pleuropulmonary blastoma (PPB), there should be a strong suspicion for malignancy in any infant presenting with pneumothorax and CPAM. (See <a class="local">'Association with malignancy'</a> below.)</p><p></p><p class="headingAnchor" id="H15"><span class="h2">Childhood presentation</span><span class="headingEndMark"> — </span>Approximately one-third of CPAMs are diagnosed after the neonatal period. These lesions typically are CPAM types 1, 2, or 4 and tend to be smaller than CPAMs that present with respiratory symptoms at birth.</p><p class="bulletIndent1"><span class="glyph">●</span>A common presentation in older children is recurrent pneumonia [<a href="#rid48">48,49</a>]. Other presenting complaints include cough, dyspnea, and/or cyanosis [<a href="#rid49">49</a>]. Findings on physical examination include decreased breath sounds over the lesion, hyperresonance, and chest wall asymmetry with a bulge on the affected side.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CPAMs can also present with spontaneous pneumothorax. Because pneumothorax is most often associated with type 4 CPAMs, and type 4 CPAM is associated with malignancy, there should be a strong suspicion for malignancy in any child presenting with pneumothorax and CPAM [<a href="#rid5">5</a>]. (See <a class="local">'Association with malignancy'</a> below.)</p><p></p><p>In a report of 12 patients who were diagnosed with CPAM between 6 months and 23 years of age (mean age 6.7 years), nine presented with recurrent pulmonary infections, one presented with pneumothorax, and two were discovered as incidental findings [<a href="#rid50">50</a>]. Among the 11 patients who underwent surgical resection of CPAM, type 1 CPAMs were identified in seven patients and type 2 CPAMs were identified in four patients.</p><p class="headingAnchor" id="H17"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H18"><span class="h2">History</span><span class="headingEndMark"> — </span>Regardless of the patient's age and presenting signs and symptoms, the family history should be explored in detail for cancers and cystic lesions that might suggest familial pleuropulmonary blastoma (PPB) syndrome. These include renal cystic disease, small bowel polyps, childhood cancers or dysplasias, and a history of spontaneous pneumothorax  (<a class="graphic graphic_table graphicRef102602" href="/d/graphic/102602.html" rel="external">table 1</a>). (See <a class="local">'Pleuropulmonary blastoma'</a> below.)</p><p class="headingAnchor" id="H19"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>The diagnosis of congenital pulmonary airway malformation (CPAM) is made by radiographic imaging. A minority of lesions detected by fetal ultrasonography will resolve during gestation, but most lesions that are present at birth will persist [<a href="#rid2">2</a>]. (See <a class="local">'Prenatal presentation'</a> above and  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management", section on 'Prenatal course'</a>.)</p><p class="headingAnchor" id="H116169897"><span class="h3">Suggested protocol</span><span class="headingEndMark"> — </span>We suggest the following approach to imaging:</p><p class="bulletIndent1"><span class="glyph">●</span>All infants with a prenatal diagnosis of CPAM should have a chest radiograph in the neonatal period, even if they are asymptomatic and even if the lesion appeared to resolve on serial prenatal ultrasounds.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptomatic newborns should be further evaluated with advanced thoracic imaging (contrast-enhanced computed tomography [CT] or MRI) to further define the lesion and distinguish it from other developmental anomalies of the lung, as part of preoperative planning. The use of intravascular contrast may be helpful to delineate the vascular supply of the lesion. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/d/html/6980.html" rel="external">"Radiographic appearance of developmental anomalies of the lung"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Asymptomatic infants also should have advanced thoracic imaging to confirm the diagnosis and further evaluate the lesion, but the timing depends on risk characteristics (symptoms and results of chest radiography). We perform the advanced imaging immediately for infants with characteristics suggesting increased risk for complications (large lesions on chest radiograph, bilateral or multifocal cysts, a family history of PPB-associated conditions, or pneumothorax)  (<a class="graphic graphic_algorithm graphicRef102532" href="/d/graphic/102532.html" rel="external">algorithm 1</a>). For infants without these characteristics, we perform the advanced thoracic imaging by six months of age.</p><p></p><p class="bulletIndent1">The CT or MRI should be performed even in infants with normal chest radiographs because plain radiographs often fail to detect CPAM in asymptomatic neonates. As an example, in one case series of asymptomatic infants with prenatally diagnosed CPAM, the chest radiograph appeared normal at birth in 12 of 29 patients (41 percent) [<a href="#rid38">38</a>]. However, when CT scan was performed at 45 days of age, cystic lung abnormalities were seen on CT scan in 11 of the 12 infants who had normal chest radiographs at birth. Chest ultrasound has also been used to monitor these lesions, but CT and MRI are better validated [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If CPAM is not diagnosed prenatally and first presents in the newborn or child, the diagnosis usually can be made on a plain radiograph, though CT or MRI of the chest is still recommended [<a href="#rid7">7,52-54</a>].</p><p></p><p class="headingAnchor" id="H116168906"><span class="h3">Radiographic appearance</span><span class="headingEndMark"> — </span>CPAM types 1, 2, and 4 are characterized by air-filled cysts. Radiography does not reliably distinguish among them. However, types 1 and 4 tend to appear as a single lesion, with one or a few large cysts that may be entirely air-filled or have air-fluid levels  (<a class="graphic graphic_diagnosticimage graphicRef76692" href="/d/graphic/76692.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef56702" href="/d/graphic/56702.html" rel="external">image 4</a>) [<a href="#rid5">5</a>]. In type 2, the numerous small cysts appear more homogenous, with a "bubbly" appearance  (<a class="graphic graphic_diagnosticimage graphicRef62424" href="/d/graphic/62424.html" rel="external">image 5</a> and <a class="graphic graphic_diagnosticimage graphicRef75275" href="/d/graphic/75275.html" rel="external">image 6</a>). In contrast, type 3 CPAM often appears as a large, solid, homogeneous mass. There is usually a marked shift of the mediastinal contents to the contralateral side with hypoplasia of the ipsilateral lung due to mass effect. The presence of pneumothorax, or bilateral or multifocal cysts, strongly suggests CPAM type 4 [<a href="#rid5">5</a>]. These distinctions are clinically important because type 4 is associated with malignancy (PPB). (See <a class="local">'Pleuropulmonary blastoma'</a> below.)</p><p>CT scans of the chest correlate with pathologic findings. In one report, preoperative CT findings were compared with pathologic findings [<a href="#rid54">54</a>]. CT accurately identified both small (&lt;2 cm in diameter) and large cysts and whether they were filled with air and/or fluid. Areas of consolidation corresponded to glandular or bronchiolar structures; this was observed in 43 percent of the scans. The area around cystic lesions where attenuation was lower than normal lung represented microcysts blending into normal lung parenchyma; this feature was seen in 29 percent of the CT scans.</p><p>CT has poor diagnostic accuracy for distinguishing PPB from benign cystic lung lesions (sensitivity 58 percent, specificity 83 percent [<a href="#rid55">55</a>]). As a result, surgical involvement for diagnosis and management is important for any patient with risk factors for PPB, including pathogenic <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank"><i>DICER1</i></a> variants, or any imaging findings suspicious for PPB. (See <a class="local">'Pleuropulmonary blastoma'</a> below.)</p><p class="headingAnchor" id="H1990051564"><span class="h2">Genetic testing</span><span class="headingEndMark"> — </span>We suggest genetic testing for pathogenic variants in the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank"><i>DICER1</i></a> gene for all infants and children with CPAM to help identify those at increased risk for PPB [<a href="#rid56">56</a>]. Genetic testing is especially important for those with multiseptated, multiple, or bilateral cysts or other risk factors for PPB, described below. A list of <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fgtr%2Fconditions%2FC1266144%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4trz%2FHgqPF5O7b%2FosjhMokBiXON0yvqk1PrdXSD8Qih9eLw%3D%3D&amp;TOPIC_ID=6346" target="_blank">laboratories that perform <i>DICER1</i> testing</a> is available at the Genetic Testing Registry website. Approximately 70 percent of PPBs are associated with pathogenic germline <em>DICER1</em> variants [<a href="#rid57">57</a>], and early identification of at-risk individuals is important in their management. (See <a class="local">'Pleuropulmonary blastoma'</a> below.)</p><p class="headingAnchor" id="H23"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of CPAM includes bronchopulmonary sequestration (BPS). On prenatal ultrasound, BPS appears as a well-defined, homogeneous, echodense mass [<a href="#rid42">42</a>]. In contrast to CPAM, BPS usually has no connection to the tracheobronchial tree and is supplied by an anomalous systemic artery rather than the pulmonary circulation. The systemic arterial supply can be demonstrated by color flow Doppler. However, hybrid lesions with histologic characteristics of CPAM and a systemic arterial supply have been reported [<a href="#rid58">58</a>]. In a series of 50 patients with BPS, 50 percent of the cases were associated with CPAMs [<a href="#rid59">59</a>]. (See  <a class="medical medical_review" href="/d/html/6341.html" rel="external">"Bronchopulmonary sequestration"</a>.)</p><p>In addition to BPS, the differential diagnosis of CPAM includes congenital diaphragmatic hernia, bronchogenic cyst, congenital lobar emphysema, and localized pulmonary interstitial emphysema that may arise in patients receiving mechanical ventilation, and pneumatoceles (which can be sequelae of bacterial pneumonia, especially due to staphylococcal infection). These disorders usually can be distinguished from CPAM based on the radiographic appearance and clinical history. (See  <a class="medical medical_review" href="/d/html/6350.html" rel="external">"Congenital lobar emphysema"</a> and  <a class="medical medical_review" href="/d/html/6980.html" rel="external">"Radiographic appearance of developmental anomalies of the lung"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H111334363"><span class="h2">Prenatal management</span><span class="headingEndMark"> — </span>Management of fetuses with prenatally diagnosed congenital pulmonary airway malformation (CPAM) includes assessment for associated abnormalities and serial ultrasound examinations to monitor changes in the CPAM and development of hydrops. Fetuses with large CPAMs and/or hydrops have a poor prognosis [<a href="#rid2">2</a>]. In this case, treatment options include antenatal corticosteroids, drainage procedures, fetal surgery, or early delivery. These considerations are discussed in detail in a separate topic review. (See  <a class="medical medical_review" href="/d/html/14207.html" rel="external">"Congenital pulmonary airway malformation: Prenatal diagnosis and management"</a>.)</p><p class="headingAnchor" id="H111334395"><span class="h2">Postnatal management</span><span class="headingEndMark"> — </span>The postnatal management of CPAM depends on whether the patient has respiratory distress or is asymptomatic [<a href="#rid60">60</a>].</p><p class="headingAnchor" id="H107006232"><span class="h3">Symptomatic patients</span><span class="headingEndMark"> — </span>In symptomatic patients, CPAM is treated by surgical resection [<a href="#rid2">2,12,61-65</a>]. Resection is frequently required in newborns with significant respiratory distress, but it is often done electively in older children who present with less acute symptoms. In older children, resection is usually performed to prevent recurrent infection and to eliminate concerns regarding malignancy. (See <a class="local">'Pleuropulmonary blastoma'</a> below.)</p><p>The surgery is curative and has few complications. Lobectomy is generally preferred to wedge resection because of the technical difficulty in identifying planes of dissection with some lesions, increased morbidity associated with partial resections in some reports, and possibility of leaving residual disease [<a href="#rid2">2,66,67</a>]. (See <a class="local">'Outcome'</a> below.)</p><p class="headingAnchor" id="H26"><span class="h3">Asymptomatic patients</span><span class="headingEndMark"> — </span>Close observation during the neonatal period is important because some infants are asymptomatic immediately after birth but then become symptomatic as the cystic lung lesions expand due to replacement of the fluid with air [<a href="#rid32">32</a>]. For infants and children who remain completely asymptomatic, the decision between surgical management and observation and the optimal timing for surgical excision are controversial and there is a significant lack of consistency reported among pediatric surgeons [<a href="#rid68">68-70</a>]. Efforts to identify a "core outcome set," using Delphi methodology, to inform decisions regarding surgical intervention for asymptomatic children with CPAM did not demonstrate a high degree of concordance among European practices [<a href="#rid71">71</a>].</p><p>The main rationale for surgery is that it eliminates the risks of future infection and the potential for malignant transformation [<a href="#rid2">2,72-74</a>]. However, the magnitude of these risks is poorly established. The estimated frequency of infection developing in an infant who is asymptomatic at birth and does not undergo surgery is probably approximately 5 to 10 percent, as discussed below (see <a class="local">'Infection'</a> below). In addition, there are fewer postoperative complications in patients undergoing elective surgery compared with those undergoing surgery after infectious symptoms develop (10 percent versus 32 percent in one meta-analysis) [<a href="#rid75">75</a>]. The risk of malignancy is extremely low, except in type 4 CPAMs, although type 1 lesions may also have some malignant potential (see <a class="local">'Association with malignancy'</a> below). A secondary consideration is that early surgery may have advantages for compensatory lung growth. However, the available small case series of infants with congenital lung malformations have demonstrated little or no correlation between age at lobectomy and pulmonary function, perhaps because pulmonary function outcomes are good in most patients [<a href="#rid76">76,77</a>]. (See <a class="local">'Outcome'</a> below.)</p><p>The main rationale in favor of observation is that surgery may be entirely avoided for some patients. The drawbacks of the observation strategy are the risk of infection developing within the cysts, the low but present risk of malignant transformation, and radiation exposure. Proponents of this approach cite the relatively low rate of infection (5 to 13 percent) [<a href="#rid78">78,79</a>] and point out that only one case has been reported of pleuropulmonary blastoma (PPB) arising in an asymptomatic, antenatally diagnosed CPAM [<a href="#rid68">68</a>]. Nonetheless, they acknowledge that surgery should be considered for infants with high-risk features (see <a class="local">'High risk'</a> below). In some reports, spontaneous regression has been reported in up to 20 percent of asymptomatic infants with congenital cystic lesions confirmed by CT scan in the neonatal period [<a href="#rid38">38,80</a>]. However, such cases are not well documented and are probably rare or represent cases of extralobar pulmonary sequestration rather than CPAM.</p><p>For asymptomatic infants and children, our management depends on the initial evaluation, including whether the chest radiograph has features suggesting an increased risk for developing complications, as discussed in the following sections.</p><p class="headingAnchor" id="H1568822012"><span class="h4">High risk</span><span class="headingEndMark"> — </span>We suggest surgical resection for asymptomatic infants and children with any the following features  (<a class="graphic graphic_algorithm graphicRef102532" href="/d/graphic/102532.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Large lesion (occupying &gt;20 percent of the hemithorax)</p><p class="bulletIndent1"><span class="glyph">●</span>Bilateral or multifocal cysts</p><p class="bulletIndent1"><span class="glyph">●</span>Pneumothorax</p><p class="bulletIndent1"><span class="glyph">●</span>Family history of DICER1 syndrome or PPB-associated conditions (including lung cysts, spontaneous pneumothorax, and several specific childhood cancers or dysplasias  (<a class="graphic graphic_table graphicRef102602" href="/d/graphic/102602.html" rel="external">table 1</a>)) (see <a class="local">'Pleuropulmonary blastoma'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Pathogenic <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank"><i>DICER1</i></a> <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank">variants</a></p><p></p><p>For such patients, we perform advanced thoracic imaging (CT or MRI) immediately to confirm the diagnosis and further evaluate the lesion. This is followed by early surgical resection during the index hospitalization, if practical, or by six months of age at the latest.</p><p class="headingAnchor" id="H1568822018"><span class="h4">Low risk</span><span class="headingEndMark"> — </span>For asymptomatic infants and children with small lesions and <strong>none</strong> of the high-risk features outlined above, either elective surgical resection or conservative management with observation are reasonable options  (<a class="graphic graphic_algorithm graphicRef102532" href="/d/graphic/102532.html" rel="external">algorithm 1</a>) [<a href="#rid2">2</a>]. We choose among these options after a detailed discussion with the family about the relative advantages and disadvantages of each approach. In particular, the family should understand that children who do not undergo surgery have a risk of developing infection in the cyst, and that outcomes of surgery are generally excellent. (See <a class="local">'Infection'</a> below and <a class="local">'Outcome'</a> below.)</p><p>If surgical resection is chosen for an asymptomatic, low-risk patient, it is usually performed after the neonatal period and before 12 months of age, but the optimal timing has not been established and practice varies [<a href="#rid81">81,82</a>]. We and others prefer to do the surgery when the infant is between 6 and 12 months of age [<a href="#rid32">32</a>]. Other groups have suggested earlier timeframes for elective surgery, between three and six months of age [<a href="#rid80">80,83-85</a>] or even between one and two months of age [<a href="#rid86">86</a>]. Minimally invasive surgery for asymptomatic patients with CPAM during infancy is now commonly performed in many centers, and most reports have high success rates without significant postoperative complications [<a href="#rid87">87-91</a>].</p><p>If observation is chosen, we suggest close clinical follow-up during the first year of life to monitor for the development of symptoms of respiratory distress or infection. In addition, we suggest routine imaging at least annually. Both chest radiographs and advanced thoracic imaging (CT or MRI) have been recommended for monitoring of these patients, and there is no consensus on the optimal strategy for imaging.</p><p class="headingAnchor" id="H111335186"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>The most common complication of congenital pulmonary airway malformation (CPAM) is recurrent pulmonary infection. In some cases, this may be the presenting sign. A rare complication is spontaneous hemopneumothorax [<a href="#rid92">92</a>]. The development of malignancy in some patients with previously unrecognized CPAM, while extremely rare, is another reason for the recommendation to resect the lesions, even in asymptomatic patients.</p><p class="headingAnchor" id="H1151155570"><span class="h2">Infection</span><span class="headingEndMark"> — </span>For infants who are asymptomatic at birth, the risk of developing infection is not well described. It is clear that some of these infants will develop infection during the first few years of life if surgery is not performed. The most reliable estimates are that infection probably develops in 5 to 10 percent of those managed conservatively, and that most of these infections occur within the first three years of life [<a href="#rid45">45,46,78,93,94</a>]. Another case series report that symptoms developed in only 3 percent at median follow-up of five years [<a href="#rid95">95</a>]. These estimates reflect series in which all or most cases were identified on prenatal ultrasound. Older case series in which more infants were diagnosed postnatally report rates of infection as high as 35 percent [<a href="#rid96">96</a>].</p><p class="headingAnchor" id="H31"><span class="h2">Association with malignancy</span><span class="headingEndMark"> — </span>Reported associations with CPAM include pleuropulmonary blastoma (PPB) and bronchoalveolar carcinoma (BAC) [<a href="#rid97">97</a>]. Rhabdomyosarcomas originating in a CPAM have been reported [<a href="#rid98">98,99</a>], but these are now thought to have been cases of PPB [<a href="#rid100">100</a>].</p><p class="headingAnchor" id="H32"><span class="h3">Pleuropulmonary blastoma</span><span class="headingEndMark"> — </span>PPB is a rare lung tumor of childhood but is more common in children with CPAM and especially those in whom the lung lesion is first detected postnatally [<a href="#rid101">101,102</a>]. In a large case series, PPB was identified in 15 of 177 (9 percent) of children with lung lesions that were not identified prenatally, compared with none of the 344 children with prenatally identified lung lesions [<a href="#rid102">102</a>]. Fewer than 500 cases have been reported, most presenting in children younger than six years of age [<a href="#rid68">68,103</a>]. Most reported cases of PPB have presented after birth, and there are only a few case reports of PPB arising in children with cystic lung lesions identified antenatally. In one study, factors favoring a diagnosis of CPAM rather than PPB included prenatal detection (odds ratio [OR] 89.4), presence of a systemic feeding vessel (OR 61.7), asymptomatic (OR 8.0), and hyperinflated lung (OR 6.6) [<a href="#rid104">104</a>]. Thus, a neonate with an asymptomatic CPAM identified prenatally has a low risk of PPB, unless there are additional risk factors, as described below.</p><p>Risk factors suggesting a substantial risk of malignancy are [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>DICER1 syndrome or a family history of PPB or related diseases</strong> – PPB can be associated with DICER1 syndrome (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.omim.org%252Fentry%252F601200%26data%3D02%7C01%7CSarah.Rush%2540wolterskluwer.com%7Cffc2e8870fb24c66d5aa08d706040a21%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C636984486724112902%26sdata%3D7DbjrR3ymWBCUkcC5U89M6g0MWCcDpDerlmp2OXL9pg%253D%26reserved%3D0&amp;token=lyMNIpxRzJtHmsIwF%2FqLUWOCx49IiSOUDWbzvBj8Qv35bTvkNdMRnlB4pIl%2F%2Fedp9k7T%2B8XZVOCe8%2F4B2vc8QH3R6MuXCg7MG7y7y3ao0o%2FNs2IhzwgWtrlUrAtro7HMtJzYSPISZbtY06V3i6r4gPt24mPaRrs3AvIY64%2FDaYolgqmMSv87F0fEZ6YvwEHXgdZnN0RDUJvByh%2BKhOoIO6Wr6Lmu0%2FqtC%2B2GJsoM7rbB9bx4JCDgoJse4HlHeKBUI9viSsg0BM3qud6nn%2FVRHT4nc1ffpOX9Xouv4AV%2BgwOkkqoJoFAaG7XnRiIwyMjf1OVI4hwWmUZ6iSxgSxV8Zg%3D%3D&amp;TOPIC_ID=6346" target="_blank">MIM #601200</a>), a hereditary cancer predisposition syndrome related to mutations in the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank"><i>DICER1</i></a> gene [<a href="#rid105">105</a>]. The inheritance pattern is autosomal dominant with decreased penetrance, and screening is summarized in a review article [<a href="#rid56">56</a>]. Affected family are predisposed to PPB, ovarian or renal tumors, or a variety of other malignancies, most of which arise during childhood or early adulthood  (<a class="graphic graphic_table graphicRef102602" href="/d/graphic/102602.html" rel="external">table 1</a>) [<a href="#rid103">103,106,107</a>]. Other associated features may include cystic lesions (including renal cystic disease), small bowel polyps, thyroid disease (multinodular goiter and cancer [<a href="#rid108">108</a>]), and macrocephaly [<a href="#rid109">109</a>]. (See  <a class="medical medical_review" href="/d/html/5835.html" rel="external">"Thyroid nodules and cancer in children", section on 'Genetic predisposition'</a> and  <a class="medical medical_review" href="/d/html/6748.html" rel="external">"Prenatal sonographic diagnosis of cystic kidney disease", section on 'Cystic tumors'</a> and  <a class="medical medical_review" href="/d/html/7750.html" rel="external">"Rhabdomyosarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis", section on 'Inherited syndromes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type 4 CPAM</strong> – Type 4 CPAM should be considered malignant lesions because approximately 30 percent of PPB present in a purely cystic form that is indistinguishable from nonmalignant cysts [<a href="#rid5">5,110-112</a>]. Indeed, there is increasing evidence that all type 4 CPAMs are actually cystic PPB [<a href="#rid5">5</a>]. Because it is difficult to distinguish between CPAM types 1 and 4, some cases classified as CPAM type 1 are actually cystic PPB. As noted above, the presence of a systemic feeding vessel identified on CT supports a diagnosis of CPAM rather than PPB (OR 61.7) [<a href="#rid104">104</a>]. However, this information has limited clinical utility because systemic feeding vessels are identified on only approximately 25 percent of infants with CPAM.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cysts that are bilateral or multifocal</strong> – There is a substantial risk of malignancy for a child presenting with bilateral or multifocal lung cysts because type 4 CPAMs often have this appearance and carry a malignancy risk. Type 4 CPAMs also may present as a large, air-filled cyst. Type 1 and 2 lesions can also be large and air-filled; type 1 lesions are rarely associated with malignancy, and type 2 lesions have no malignancy risk.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pneumothorax</strong> – Pneumothorax is a prominent feature of type 4 CPAM, occurring in approximately 40 percent of cases later diagnosed as PPB [<a href="#rid5">5</a>].</p><p></p><p class="headingAnchor" id="H33"><span class="h3">Bronchoalveolar carcinoma</span><span class="headingEndMark"> — </span>There is a weak association of CPAM type 1 with bronchoalveolar carcinoma (BAC), also known as adenocarcinoma in situ [<a href="#rid97">97,113,114</a>]. In patients with CPAM, BAC is usually discovered incidentally in cysts resected during adolescence or adulthood (range 6 months to 75 years of age) [<a href="#rid5">5</a>]. It has been estimated that BAC eventually develops in approximately 1 percent of unresected CPAM type 1 [<a href="#rid106">106</a>], but the true rate of this malignancy and its clinical significance remains unclear.</p><p class="headingAnchor" id="H34"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>Among congenital pulmonary airway malformation (CPAM) diagnosed prenatally, the overall survival rate is more than 95 percent and the presence of fetal hydrops is an important predictor of mortality. For most symptomatic or asymptomatic infants with CPAM, surgical excision in the neonatal period is curative and the prognosis for survival is excellent [<a href="#rid2">2,96,115,116</a>]. Although the remaining lung parenchyma undergoes compensatory growth and development [<a href="#rid117">117</a>], the pulmonary function outcomes vary across different reports, probably reflecting differences in patient selection [<a href="#rid76">76,118-122</a>]. As examples, in a series of infants with congenital lung malformations who were mostly asymptomatic and underwent elective surgical resection before one year of age, more than 80 percent had normal pulmonary function testing during childhood [<a href="#rid77">77</a>]. In a different series in which surgery was performed for symptomatic lung lesions, patients who were managed surgically had mildly impaired exercise tolerance by eight years, and one-half had pulmonary function testing abnormalities, most of which were mild [<a href="#rid121">121</a>]. In this same cohort, patients who were asymptomatic and managed conservatively generally had normal pulmonary function tests but still had mildly reduced exercise tolerance.</p><p>The good overall prognosis described above reflects the predominance of the type 1 lesion. The prognosis for type 2 and 3 CPAMs is not as favorable, although recovery is possible [<a href="#rid7">7,9,10,123-125</a>]. Outcomes in infants with type 2 lesions may be influenced by the severity of the accompanying congenital anomalies. Infants with type 3 lesions frequently have severe hypoplasia of the contralateral lung and are at risk for developing pulmonary hypertension [<a href="#rid126">126,127</a>].</p><p>The outcome of type 4 CPAM is also quite good with surgical resection. However, because this lesion probably represents cystic pleuropulmonary blastoma (PPB), oncologic consultation and complete surgical resection is essential. (See <a class="local">'Pleuropulmonary blastoma'</a> above.)</p><p class="headingAnchor" id="H35"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and types</strong> – Congenital pulmonary airway malformation (CPAM), previously known as congenital cystic adenomatoid malformation (CCAM), is a developmental anomaly of the respiratory tract. CPAMs are categorized as types 0 through 4, which are defined pathologically and have different clinical presentations and prognoses. Type 1 CPAM is most common, and type 4 CPAM has high malignant potential. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Many infants with CPAM are identified by routine prenatal ultrasound examination. Approximately one-quarter of these infants have symptoms at birth, including mild or severe respiratory distress, and some have associated congenital anomalies. Approximately one-third of CPAM are identified later in infancy or childhood, presenting with recurrent pneumonia or spontaneous pneumothorax. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pleuropulmonary blastoma (PPB)</strong> – PPB is a rare lung tumor of childhood but is more common in children with CPAM (especially bilateral, multifocal, or presenting with pneumothorax), pathogenic <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank"><i>DICER1</i></a> variants, and/or a family history of PPB or related conditions (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank">DICER1</a> syndrome)  (<a class="graphic graphic_table graphicRef102602" href="/d/graphic/102602.html" rel="external">table 1</a>). (See <a class="local">'Pleuropulmonary blastoma'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – For all infants with a prenatal diagnosis of CPAM, the postnatal evaluation should include  (<a class="graphic graphic_algorithm graphicRef102532" href="/d/graphic/102532.html" rel="external">algorithm 1</a>) (see <a class="local">'Evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chest radiograph – Perform in the neonatal period, even if the infant is asymptomatic and even if the lesion appeared to resolve on serial prenatal ultrasounds.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Advanced imaging – The timing depends on symptoms and on the results of the initial chest radiograph. Advanced imaging should be performed even in infants with normal chest radiographs because plain radiographs often fail to detect CPAM in asymptomatic neonates. (See <a class="local">'Suggested protocol'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Genetic testing – Test for pathogenic <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank"><i>DICER1</i></a> variants. (See <a class="local">'Genetic testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic infants</strong> – In patients with CPAM that is causing any respiratory symptoms (respiratory distress or tachypnea), we recommend surgical resection rather than observation (<a class="grade" href="https://medilib.ir/uptodate/show/grade_1" rel="external">Grade 1A</a>)  (<a class="graphic graphic_algorithm graphicRef102532" href="/d/graphic/102532.html" rel="external">algorithm 1</a>). All resected cysts should be carefully examined for evidence of malignancy. (See <a class="local">'Symptomatic patients'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Asymptomatic infants</strong> – Asymptomatic infants with a prenatal diagnosis of CPAM should be evaluated with a chest radiograph in the neonatal period. Subsequent management depends on whether there are characteristics that suggest a high risk of complications  (<a class="graphic graphic_algorithm graphicRef102532" href="/d/graphic/102532.html" rel="external">algorithm 1</a>):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For infants and children with high-risk characteristics (large lesions on chest radiograph, bilateral or multifocal cysts, pneumothorax, pathogenic <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F606241&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoRXpLk1HWXNplBoRtoeB89&amp;TOPIC_ID=6346" target="_blank">DICER1</a> variants, or a family history of PPB-associated conditions  (<a class="graphic graphic_table graphicRef102602" href="/d/graphic/102602.html" rel="external">table 1</a>)), we suggest early surgical resection rather than observation (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). These infants should be evaluated with CT or MRI prior to surgery to confirm the diagnosis and further evaluate the lesion. (See <a class="local">'High risk'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For infants and children with small lesions and none of the other high-risk features outlined above, either elective surgical resection or conservative management with observation are reasonable options. If surgical resection is chosen for such patients, it is usually performed after the neonatal period but before 12 months of age. If observation is chosen, infants should have close follow up during the first year of life to monitor for the development of symptoms of respiratory distress or infection, as well as imaging with CT or MRI by six months of age and annually thereafter. (See <a class="local">'Low risk'</a> above.)</p><p></p><p class="bulletIndent2">For infants who are asymptomatic at birth, the risk of developing infection is not well delineated. It is clear that some of these infants will develop infection during the first few years of life if surgery is not performed, but the estimates of the risk for infection ranges from 3 to 30 percent. (See <a class="local">'Infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcome</strong> – For the majority of infants with CPAM, surgical excision in the neonatal period is curative and the prognosis excellent. (See <a class="local">'Outcome'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shanti CM, Klein MD. Cystic lung disease. Semin Pediatr Surg 2008; 17:2.</a></li><li><a class="nounderline abstract_t">Baird R, Puligandla PS, Laberge JM. Congenital lung malformations: informing best practice. Semin Pediatr Surg 2014; 23:270.</a></li><li><a class="nounderline abstract_t">Taguchi T, Suita S, Yamanouchi T, et al. Antenatal diagnosis and surgical management of congenital cystic adenomatoid malformation of the lung. Fetal Diagn Ther 1995; 10:400.</a></li><li><a class="nounderline abstract_t">Gajewska-Knapik K, Impey L. Congenital lung lesions: Prenatal diagnosis and intervention. Semin Pediatr Surg 2015; 24:156.</a></li><li><a class="nounderline abstract_t">Priest JR, Williams GM, Hill DA, et al. Pulmonary cysts in early childhood and the risk of malignancy. Pediatr Pulmonol 2009; 44:14.</a></li><li><a class="nounderline abstract_t">Gornall AS, Budd JL, Draper ES, et al. Congenital cystic adenomatoid malformation: accuracy of prenatal diagnosis, prevalence and outcome in a general population. Prenat Diagn 2003; 23:997.</a></li><li><a class="nounderline abstract_t">De Santis M, Masini L, Noia G, et al. Congenital cystic adenomatoid malformation of the lung: antenatal ultrasound findings and fetal-neonatal outcome. Fifteen years of experience. Fetal Diagn Ther 2000; 15:246.</a></li><li><a class="nounderline abstract_t">Takeda S, Miyoshi S, Inoue M, et al. Clinical spectrum of congenital cystic disease of the lung in children. Eur J Cardiothorac Surg 1999; 15:11.</a></li><li><a class="nounderline abstract_t">Pinter A, Kalman A, Karsza L, et al. Long-term outcome of congenital cystic adenomatoid malformation. Pediatr Surg Int 1999; 15:332.</a></li><li><a class="nounderline abstract_t">Evrard V, Ceulemans J, Coosemans W, et al. Congenital parenchymatous malformations of the lung. World J Surg 1999; 23:1123.</a></li><li><a class="nounderline abstract_t">Nishibayashi SW, Andrassy RJ, Woolley MM. Congenital cystic adenomatoid malformation: 1 30-year experience. J Pediatr Surg 1981; 16:704.</a></li><li><a class="nounderline abstract_t">Nuchtern JG, Harberg FJ. Congenital lung cysts. Semin Pediatr Surg 1994; 3:233.</a></li><li><a class="nounderline abstract_t">Kunisaki SM, Fauza DO, Nemes LP, et al. Bronchial atresia: the hidden pathology within a spectrum of prenatally diagnosed lung masses. J Pediatr Surg 2006; 41:61.</a></li><li><a class="nounderline abstract_t">Riedlinger WF, Vargas SO, Jennings RW, et al. Bronchial atresia is common to extralobar sequestration, intralobar sequestration, congenital cystic adenomatoid malformation, and lobar emphysema. Pediatr Dev Pathol 2006; 9:361.</a></li><li><a class="nounderline abstract_t">Cass DL, Quinn TM, Yang EY, et al. Increased cell proliferation and decreased apoptosis characterize congenital cystic adenomatoid malformation of the lung. J Pediatr Surg 1998; 33:1043.</a></li><li><a class="nounderline abstract_t">Fromont-Hankard G, Philippe-Chomette P, Delezoide AL, et al. Glial cell-derived neurotrophic factor expression in normal human lung and congenital cystic adenomatoid malformation. Arch Pathol Lab Med 2002; 126:432.</a></li><li><a class="nounderline abstract_t">Cangiarella J, Greco MA, Askin F, et al. Congenital cystic adenomatoid malformation of the lung: insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1. Mod Pathol 1995; 8:913.</a></li><li><a class="nounderline abstract_t">Berrocal T, Madrid C, Novo S, et al. Congenital anomalies of the tracheobronchial tree, lung, and mediastinum: embryology, radiology, and pathology. Radiographics 2004; 24:e17.</a></li><li><a class="nounderline abstract_t">Wilson RD, Hedrick HL, Liechty KW, et al. Cystic adenomatoid malformation of the lung: review of genetics, prenatal diagnosis, and in utero treatment. Am J Med Genet A 2006; 140:151.</a></li><li><a class="nounderline abstract_t">Doktor F, Antounians L, Lacher M, Zani A. Congenital lung malformations: Dysregulated lung developmental processes and altered signaling pathways. Semin Pediatr Surg 2022; 31:151228.</a></li><li><a class="nounderline abstract_t">Zylak CJ, Eyler WR, Spizarny DL, Stone CH. Developmental lung anomalies in the adult: radiologic-pathologic correlation. Radiographics 2002; 22 Spec No:S25.</a></li><li><a class="nounderline abstract_t">Stocker JT, Drake RM, Madewell JE. Cystic and congenital lung disease in the newborn. Perspect Pediatr Pathol 1978; 4:93.</a></li><li><a class="nounderline abstract_t">Landing BH, Dixon LG. Congenital malformations and genetic disorders of the respiratory tract (larynx, trachea, bronchi, and lungs). Am Rev Respir Dis 1979; 120:151.</a></li><li><a class="nounderline abstract_t">Stocker JT, Madewell JE, Drake RM. Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol 1977; 8:155.</a></li><li><a class="nounderline abstract_t">Stocker JT. Congenital pulmonary airway malformation - a new name for and an expanded classification of congenital cystic adenomatoid malformation of the lung. Histopathology 2002; 41:424.</a></li><li class="breakAll">Stocker JT. Congenital and developmental diseases. In: Pulmonary Pathology, Dail DH, Hammer SP (Eds), Springer, New York 1994. p.174.</li><li><a class="nounderline abstract_t">van Koningsbruggen S, Ahrens F, Brockmann M, et al. Congenital cystic adenomatoid malformation type 4. Pediatr Pulmonol 2001; 32:471.</a></li><li><a class="nounderline abstract_t">Stocker JT. Cystic lung disease in infants and children. Fetal Pediatr Pathol 2009; 28:155.</a></li><li><a class="nounderline abstract_t">De Felice C, Di Maggio G, Messina M, et al. Congenital cystic adenomatoid malformation of the lung associated with esophageal atresia and tracheoesophageal fistula. Pediatr Surg Int 1999; 15:260.</a></li><li><a class="nounderline abstract_t">Krous HF, Harper PE, Perlman M. Congenital cystic adenomatoid malformation in bilateral renal agenesis. Its mitigation of Potter's syndrome. Arch Pathol Lab Med 1980; 104:368.</a></li><li><a class="nounderline abstract_t">Chowdhury MM, Chakraborty S. Imaging of congenital lung malformations. Semin Pediatr Surg 2015; 24:168.</a></li><li><a class="nounderline abstract_t">Parikh DH, Rasiah SV. Congenital lung lesions: Postnatal management and outcome. Semin Pediatr Surg 2015; 24:160.</a></li><li><a class="nounderline abstract_t">Duncombe GJ, Dickinson JE, Kikiros CS. Prenatal diagnosis and management of congenital cystic adenomatoid malformation of the lung. Am J Obstet Gynecol 2002; 187:950.</a></li><li><a class="nounderline abstract_t">Miller JA, Corteville JE, Langer JC. Congenital cystic adenomatoid malformation in the fetus: natural history and predictors of outcome. J Pediatr Surg 1996; 31:805.</a></li><li><a class="nounderline abstract_t">Bush A, Hogg J, Chitty LS. Cystic lung lesions - prenatal diagnosis and management. Prenat Diagn 2008; 28:604.</a></li><li><a class="nounderline abstract_t">Cavoretto P, Molina F, Poggi S, et al. Prenatal diagnosis and outcome of echogenic fetal lung lesions. Ultrasound Obstet Gynecol 2008; 32:769.</a></li><li><a class="nounderline abstract_t">Kunisaki SM, Ehrenberg-Buchner S, Dillman JR, et al. Vanishing fetal lung malformations: Prenatal sonographic characteristics and postnatal outcomes. J Pediatr Surg 2015; 50:978.</a></li><li><a class="nounderline abstract_t">Sauvat F, Michel JL, Benachi A, et al. Management of asymptomatic neonatal cystic adenomatoid malformations. J Pediatr Surg 2003; 38:548.</a></li><li><a class="nounderline abstract_t">Butterworth SA, Blair GK. Postnatal spontaneous resolution of congenital cystic adenomatoid malformations. J Pediatr Surg 2005; 40:832.</a></li><li><a class="nounderline abstract_t">Kunisaki SM, Barnewolt CE, Estroff JA, et al. Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival. J Pediatr Surg 2007; 42:404.</a></li><li><a class="nounderline abstract_t">Adzick NS, Harrison MR, Glick PL, et al. Fetal cystic adenomatoid malformation: prenatal diagnosis and natural history. J Pediatr Surg 1985; 20:483.</a></li><li><a class="nounderline abstract_t">Adzick NS, Harrison MR, Crombleholme TM, et al. Fetal lung lesions: management and outcome. Am J Obstet Gynecol 1998; 179:884.</a></li><li><a class="nounderline abstract_t">Crombleholme TM, Coleman B, Hedrick H, et al. Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg 2002; 37:331.</a></li><li><a class="nounderline abstract_t">Miller RK, Sieber WK, Yunis EJ. Congenital adenomatoid malformation of the lung. A report of 17 cases and review of the literature. Pathol Annu 1980; 15:387.</a></li><li><a class="nounderline abstract_t">Ruchonnet-Metrailler I, Leroy-Terquem E, Stirnemann J, et al. Neonatal outcomes of prenatally diagnosed congenital pulmonary malformations. Pediatrics 2014; 133:e1285.</a></li><li><a class="nounderline abstract_t">Karlsson M, Conner P, Ehren H, et al. The natural history of prenatally diagnosed congenital pulmonary airway malformations and bronchopulmonary sequestrations. J Pediatr Surg 2022; 57:282.</a></li><li><a class="nounderline abstract_t">Gardikis S, Didilis V, Polychronidis A, et al. Spontaneous pneumothorax resulting from congenital cystic adenomatoid malformation in a pre-term infant: case report and literature review. Eur J Pediatr Surg 2002; 12:195.</a></li><li><a class="nounderline abstract_t">Hulnick DH, Naidich DP, McCauley DI, et al. Late presentation of congenital cystic adenomatoid malformation of the lung. Radiology 1984; 151:569.</a></li><li><a class="nounderline abstract_t">Parikh D, Samuel M. Congenital cystic lung lesions: is surgical resection essential? Pediatr Pulmonol 2005; 40:533.</a></li><li><a class="nounderline abstract_t">Luján M, Bosque M, Mirapeix RM, et al. Late-onset congenital cystic adenomatoid malformation of the lung. Embryology, clinical symptomatology, diagnostic procedures, therapeutic approach and clinical follow-up. Respiration 2002; 69:148.</a></li><li><a class="nounderline abstract_t">Quercia M, Panza R, Calderoni G, et al. Lung Ultrasound: A New Tool in the Management of Congenital Lung Malformation. Am J Perinatol 2019; 36:S99.</a></li><li><a class="nounderline abstract_t">Hubbard AM, Adzick NS, Crombleholme TM, et al. Congenital chest lesions: diagnosis and characterization with prenatal MR imaging. Radiology 1999; 212:43.</a></li><li><a class="nounderline abstract_t">Hernanz-Schulman M. Cysts and cystlike lesions of the lung. Radiol Clin North Am 1993; 31:631.</a></li><li><a class="nounderline abstract_t">Kim WS, Lee KS, Kim IO, et al. Congenital cystic adenomatoid malformation of the lung: CT-pathologic correlation. AJR Am J Roentgenol 1997; 168:47.</a></li><li><a class="nounderline abstract_t">Engwall-Gill AJ, Chan SS, Boyd KP, et al. Accuracy of Chest Computed Tomography in Distinguishing Cystic Pleuropulmonary Blastoma From Benign Congenital Lung Malformations in Children. JAMA Netw Open 2022; 5:e2219814.</a></li><li><a class="nounderline abstract_t">Schultz KAP, Williams GM, Kamihara J, et al. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res 2018; 24:2251.</a></li><li><a class="nounderline abstract_t">Brenneman M, Field A, Yang J, et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res 2015; 4:214.</a></li><li><a class="nounderline abstract_t">Cass DL, Crombleholme TM, Howell LJ, et al. Cystic lung lesions with systemic arterial blood supply: a hybrid of congenital cystic adenomatoid malformation and bronchopulmonary sequestration. J Pediatr Surg 1997; 32:986.</a></li><li><a class="nounderline abstract_t">Conran RM, Stocker JT. Extralobar sequestration with frequently associated congenital cystic adenomatoid malformation, type 2: report of 50 cases. Pediatr Dev Pathol 1999; 2:454.</a></li><li><a class="nounderline abstract_t">Hegde BN, Tsao K, Hirose S. Management of Congenital Lung Malformations. Clin Perinatol 2022; 49:907.</a></li><li><a class="nounderline abstract_t">Schwartz MZ, Ramachandran P. Congenital malformations of the lung and mediastinum--a quarter century of experience from a single institution. J Pediatr Surg 1997; 32:44.</a></li><li><a class="nounderline abstract_t">Al-Bassam A, Al-Rabeeah A, Al-Nassar S, et al. Congenital cystic disease of the lung in infants and children (experience with 57 cases). Eur J Pediatr Surg 1999; 9:364.</a></li><li><a class="nounderline abstract_t">Shanmugam G, MacArthur K, Pollock JC. Congenital lung malformations--antenatal and postnatal evaluation and management. Eur J Cardiothorac Surg 2005; 27:45.</a></li><li><a class="nounderline abstract_t">Duan M, Wang L, Cao Y, et al. Results of surgical treatment of congenital cystic lung disease. Thorac Cardiovasc Surg 2005; 53:61.</a></li><li><a class="nounderline abstract_t">Stanton M, Davenport M. Management of congenital lung lesions. Early Hum Dev 2006; 82:289.</a></li><li><a class="nounderline abstract_t">Muller CO, Berrebi D, Kheniche A, Bonnard A. Is radical lobectomy required in congenital cystic adenomatoid malformation? J Pediatr Surg 2012; 47:642.</a></li><li><a class="nounderline abstract_t">Kersten CM, Rousian M, Wesseling JJ, et al. Sublobar Pulmonary Resection in Children With Congenital Lung Abnormalities: A Systematic Review. J Pediatr Surg 2023; 58:2088.</a></li><li><a class="nounderline abstract_t">Stanton M. The argument for a non-operative approach to asymptomatic lung lesions. Semin Pediatr Surg 2015; 24:183.</a></li><li><a class="nounderline abstract_t">Singh R, Davenport M. The argument for operative approach to asymptomatic lung lesions. Semin Pediatr Surg 2015; 24:187.</a></li><li><a class="nounderline abstract_t">Morini F, Zani A, Conforti A, et al. Current Management of Congenital Pulmonary Airway Malformations: A "European Pediatric Surgeons' Association" Survey. Eur J Pediatr Surg 2018; 28:1.</a></li><li><a class="nounderline abstract_t">Kersten CM, Hermelijn SM, Mullassery D, et al. The Management of Asymptomatic Congenital Pulmonary Airway Malformation: Results of a European Delphi Survey. Children (Basel) 2022; 9.</a></li><li><a class="nounderline abstract_t">d'Agostino S, Bonoldi E, Dante S, et al. Embryonal rhabdomyosarcoma of the lung arising in cystic adenomatoid malformation: case report and review of the literature. J Pediatr Surg 1997; 32:1381.</a></li><li><a class="nounderline abstract_t">Murphy JJ, Blair GK, Fraser GC, et al. Rhabdomyosarcoma arising within congenital pulmonary cysts: report of three cases. J Pediatr Surg 1992; 27:1364.</a></li><li><a class="nounderline abstract_t">Domizio P, Liesner RJ, Dicks-Mireaux C, Risdon RA. Malignant mesenchymoma associated with a congenital lung cyst in a child: case report and review of the literature. Pediatr Pathol 1990; 10:785.</a></li><li><a class="nounderline abstract_t">Kapralik J, Wayne C, Chan E, Nasr A. Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis. J Pediatr Surg 2016; 51:508.</a></li><li><a class="nounderline abstract_t">Naito Y, Beres A, Lapidus-Krol E, et al. Does earlier lobectomy result in better long-term pulmonary function in children with congenital lung anomalies? A prospective study. J Pediatr Surg 2012; 47:852.</a></li><li><a class="nounderline abstract_t">Tocchioni F, Lombardi E, Ghionzoli M, et al. Long-term lung function in children following lobectomy for congenital lung malformation. J Pediatr Surg 2017; 52:1891.</a></li><li><a class="nounderline abstract_t">Cook J, Chitty LS, De Coppi P, et al. The natural history of prenatally diagnosed congenital cystic lung lesions: long-term follow-up of 119 cases. Arch Dis Child 2017; 102:798.</a></li><li><a class="nounderline abstract_t">Thompson AJ, Sidebotham EL, Chetcuti PAJ, Crabbe DCG. Prenatally diagnosed congenital lung malformations-A long-term outcome study. Pediatr Pulmonol 2018; 53:1442.</a></li><li><a class="nounderline abstract_t">Calvert JK, Boyd PA, Chamberlain PC, et al. Outcome of antenatally suspected congenital cystic adenomatoid malformation of the lung: 10 years' experience 1991-2001. Arch Dis Child Fetal Neonatal Ed 2006; 91:F26.</a></li><li><a class="nounderline abstract_t">Sullivan KJ, Li M, Haworth S, et al. Optimal age for elective surgery of asymptomatic congenital pulmonary airway malformation: a meta-analysis. Pediatr Surg Int 2017; 33:665.</a></li><li><a class="nounderline abstract_t">Jelin EB, O'Hare EM, Jancelewicz T, et al. Optimal timing for elective resection of asymptomatic congenital pulmonary airway malformations. J Pediatr Surg 2018; 53:1001.</a></li><li><a class="nounderline abstract_t">Calvert JK, Lakhoo K. Antenatally suspected congenital cystic adenomatoid malformation of the lung: postnatal investigation and timing of surgery. J Pediatr Surg 2007; 42:411.</a></li><li><a class="nounderline abstract_t">Laberge JM, Puligandla P, Flageole H. Asymptomatic congenital lung malformations. Semin Pediatr Surg 2005; 14:16.</a></li><li><a class="nounderline abstract_t">Gulack BC, Leraas HJ, Ezekian B, et al. Outcomes following elective resection of congenital pulmonary airway malformations are equivalent after 3 months of age and a weight of 5 kg. J Pediatr Surg 2017.</a></li><li><a class="nounderline abstract_t">Khalek N, Johnson MP. Management of prenatally diagnosed lung lesions. Semin Pediatr Surg 2013; 22:24.</a></li><li><a class="nounderline abstract_t">Truitt AK, Carr SR, Cassese J, et al. Perinatal management of congenital cystic lung lesions in the age of minimally invasive surgery. J Pediatr Surg 2006; 41:893.</a></li><li><a class="nounderline abstract_t">Albanese CT, Sydorak RM, Tsao K, Lee H. Thoracoscopic lobectomy for prenatally diagnosed lung lesions. J Pediatr Surg 2003; 38:553.</a></li><li><a class="nounderline abstract_t">Vu LT, Farmer DL, Nobuhara KK, et al. Thoracoscopic versus open resection for congenital cystic adenomatoid malformations of the lung. J Pediatr Surg 2008; 43:35.</a></li><li><a class="nounderline abstract_t">Nasr A, Bass J. Thoracoscopic vs open resection of congenital lung lesions: a meta-analysis. J Pediatr Surg 2012; 47:857.</a></li><li><a class="nounderline abstract_t">Kunisaki SM, Powelson IA, Haydar B, et al. Thoracoscopic vs open lobectomy in infants and young children with congenital lung malformations. J Am Coll Surg 2014; 218:261.</a></li><li><a class="nounderline abstract_t">Lee SC, Cheng YL, Yu CP. Haemopneumothorax from congenital cystic adenomatoid malformation in a cryptorchidism patient. Eur Respir J 2000; 15:430.</a></li><li><a class="nounderline abstract_t">Aziz D, Langer JC, Tuuha SE, et al. Perinatally diagnosed asymptomatic congenital cystic adenomatoid malformation: to resect or not? J Pediatr Surg 2004; 39:329.</a></li><li><a class="nounderline abstract_t">Chetcuti PA, Crabbe DC. CAM lungs: the conservative approach. Arch Dis Child Fetal Neonatal Ed 2006; 91:F463.</a></li><li><a class="nounderline abstract_t">Ng C, Stanwell J, Burge DM, Stanton MP. Conservative management of antenatally diagnosed cystic lung malformations. Arch Dis Child 2014; 99:432.</a></li><li><a class="nounderline abstract_t">Wong A, Vieten D, Singh S, et al. Long-term outcome of asymptomatic patients with congenital cystic adenomatoid malformation. Pediatr Surg Int 2009; 25:479.</a></li><li><a class="nounderline abstract_t">Casagrande A, Pederiva F. Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review. J Thorac Oncol 2016; 11:1837.</a></li><li><a class="nounderline abstract_t">Granata C, Gambini C, Balducci T, et al. Bronchioloalveolar carcinoma arising in congenital cystic adenomatoid malformation in a child: a case report and review on malignancies originating in congenital cystic adenomatoid malformation. Pediatr Pulmonol 1998; 25:62.</a></li><li><a class="nounderline abstract_t">Ozcan C, Celik A, Ural Z, et al. Primary pulmonary rhabdomyosarcoma arising within cystic adenomatoid malformation: a case report and review of the literature. J Pediatr Surg 2001; 36:1062.</a></li><li><a class="nounderline abstract_t">Pai S, Eng HL, Lee SY, et al. Correction: Pleuropulmonary blastoma, not rhabdomyosarcoma in a congenital lung cyst. Pediatr Blood Cancer 2007; 48:370.</a></li><li><a class="nounderline abstract_t">Nasr A, Himidan S, Pastor AC, et al. Is congenital cystic adenomatoid malformation a premalignant lesion for pleuropulmonary blastoma? J Pediatr Surg 2010; 45:1086.</a></li><li><a class="nounderline abstract_t">Kunisaki SM, Lal DR, Saito JM, et al. Pleuropulmonary Blastoma in Pediatric Lung Lesions. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Zhang N, Zeng Q, Ma X, et al. Diagnosis and treatment of pleuropulmonary blastoma in children: A single-center report of 41 cases. J Pediatr Surg 2020; 55:1351.</a></li><li><a class="nounderline abstract_t">Feinberg A, Hall NJ, Williams GM, et al. Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg 2016; 51:33.</a></li><li><a class="nounderline abstract_t">Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325:965.</a></li><li><a class="nounderline abstract_t">Dusmet M. Adult lung tumours of childhood origin. Semin Pediatr Surg 2015; 24:196.</a></li><li><a class="nounderline abstract_t">Stewart DR, Best AF, Williams GM, et al. Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1. J Clin Oncol 2019; 37:668.</a></li><li><a class="nounderline abstract_t">Khan NE, Bauer AJ, Schultz KAP, et al. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study. J Clin Endocrinol Metab 2017; 102:1614.</a></li><li><a class="nounderline abstract_t">Khan NE, Bauer AJ, Doros L, et al. Macrocephaly associated with the DICER1 syndrome. Genet Med 2017; 19:244.</a></li><li><a class="nounderline abstract_t">MacSweeney F, Papagiannopoulos K, Goldstraw P, et al. An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation. Am J Surg Pathol 2003; 27:1139.</a></li><li><a class="nounderline abstract_t">Federici S, Domenichelli V, Tani G, et al. Pleuropulmonary blastoma in congenital cystic adenomatoid malformation: report of a case. Eur J Pediatr Surg 2001; 11:196.</a></li><li><a class="nounderline abstract_t">Langston C. New concepts in the pathology of congenital lung malformations. Semin Pediatr Surg 2003; 12:17.</a></li><li><a class="nounderline abstract_t">Lantuejoul S, Nicholson AG, Sartori G, et al. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors. Am J Surg Pathol 2007; 31:961.</a></li><li><a class="nounderline abstract_t">Muntean A, Banias LE, Ade-Ajayi N, et al. Neonatal congenital pulmonary airway malformation associated with mucinous adenocarcinoma and KRAS mutations. J Pediatr Surg 2022; 57:520.</a></li><li><a class="nounderline abstract_t">Davenport M, Warne SA, Cacciaguerra S, et al. Current outcome of antenally diagnosed cystic lung disease. J Pediatr Surg 2004; 39:549.</a></li><li><a class="nounderline abstract_t">Laje P, Liechty KW. Postnatal management and outcome of prenatally diagnosed lung lesions. Prenat Diagn 2008; 28:612.</a></li><li><a class="nounderline abstract_t">Zach MS, Eber E. Adult outcome of congenital lower respiratory tract malformations. Thorax 2001; 56:65.</a></li><li><a class="nounderline abstract_t">Beres A, Aspirot A, Paris C, et al. A contemporary evaluation of pulmonary function in children undergoing lung resection in infancy. J Pediatr Surg 2011; 46:829.</a></li><li><a class="nounderline abstract_t">Spoel M, van de Ven KP, Tiddens HA, et al. Lung function of infants with congenital lung lesions in the first year of life. Neonatology 2013; 103:60.</a></li><li><a class="nounderline abstract_t">Dunn A, Pearce K, Callister R, et al. Exercise capacity is not decreased in children who have undergone lung resection early in life for congenital thoracic malformations compared to healthy age-matched children. Pediatr Pulmonol 2017; 52:1340.</a></li><li><a class="nounderline abstract_t">Hijkoop A, van Schoonhoven MM, van Rosmalen J, et al. Lung function, exercise tolerance, and physical growth of children with congenital lung malformations at 8 years of age. Pediatr Pulmonol 2019; 54:1326.</a></li><li><a class="nounderline abstract_t">Farolfi A, Ghezzi M, Calcaterra V, et al. Congenital Lung Malformations: Clinical and Functional Respiratory Outcomes after Surgery. Children (Basel) 2022; 9.</a></li><li><a class="nounderline abstract_t">Laberge JM, Flageole H, Pugash D, et al. Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience. Fetal Diagn Ther 2001; 16:178.</a></li><li><a class="nounderline abstract_t">Waszak P, Claris O, Lapillonne A, et al. Cystic adenomatoid malformation of the lung: neonatal management of 21 cases. Pediatr Surg Int 1999; 15:326.</a></li><li><a class="nounderline abstract_t">Cloutier MM, Schaeffer DA, Hight D. Congenital cystic adenomatoid malformation. Chest 1993; 103:761.</a></li><li><a class="nounderline abstract_t">Atkinson JB, Ford EG, Kitagawa H, et al. Persistent pulmonary hypertension complicating cystic adenomatoid malformation in neonates. J Pediatr Surg 1992; 27:54.</a></li><li><a class="nounderline abstract_t">Rossi R, Tjan TD, Hentschel R, et al. Successful perioperative management of congenital cystic adenomatoid malformation of the lung by high frequency oscillatory ventilation--report of two cases. Klin Padiatr 1998; 210:94.</a></li></ol></div><div id="topicVersionRevision">Topic 6346 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18158136" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cystic lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25459011" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Congenital lung malformations: informing best practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8579779" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Antenatal diagnosis and surgical management of congenital cystic adenomatoid malformation of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051047" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Congenital lung lesions: Prenatal diagnosis and intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19061226" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pulmonary cysts in early childhood and the risk of malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14663837" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Congenital cystic adenomatoid malformation: accuracy of prenatal diagnosis, prevalence and outcome in a general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10867488" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Congenital cystic adenomatoid malformation of the lung: antenatal ultrasound findings and fetal-neonatal outcome. Fifteen years of experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10077367" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical spectrum of congenital cystic disease of the lung in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10415280" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Long-term outcome of congenital cystic adenomatoid malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10501874" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Congenital parenchymatous malformations of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7310605" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Congenital cystic adenomatoid malformation: 1 30-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7850363" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Congenital lung cysts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16410109" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Bronchial atresia: the hidden pathology within a spectrum of prenatally diagnosed lung masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16953677" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bronchial atresia is common to extralobar sequestration, intralobar sequestration, congenital cystic adenomatoid malformation, and lobar emphysema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9694091" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Increased cell proliferation and decreased apoptosis characterize congenital cystic adenomatoid malformation of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11900567" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Glial cell-derived neurotrophic factor expression in normal human lung and congenital cystic adenomatoid malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8751331" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Congenital cystic adenomatoid malformation of the lung: insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14610245" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Congenital anomalies of the tracheobronchial tree, lung, and mediastinum: embryology, radiology, and pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16353256" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cystic adenomatoid malformation of the lung: review of genetics, prenatal diagnosis, and in utero treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36442455" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Congenital lung malformations: Dysregulated lung developmental processes and altered signaling pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12376599" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Developmental lung anomalies in the adult: radiologic-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/366553" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cystic and congenital lung disease in the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/380420" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Congenital malformations and genetic disorders of the respiratory tract (larynx, trachea, bronchi, and lungs).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/856714" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Congenital pulmonary airway malformation - a new name for and an expanded classification of congenital cystic adenomatoid malformation of the lung</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Congenital pulmonary airway malformation - a new name for and an expanded classification of congenital cystic adenomatoid malformation of the lung</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11747251" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Congenital cystic adenomatoid malformation type 4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19842869" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cystic lung disease in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10370039" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Congenital cystic adenomatoid malformation of the lung associated with esophageal atresia and tracheoesophageal fistula.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6893124" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Congenital cystic adenomatoid malformation in bilateral renal agenesis. Its mitigation of Potter's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051049" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Imaging of congenital lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051048" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Congenital lung lesions: Postnatal management and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12388984" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prenatal diagnosis and management of congenital cystic adenomatoid malformation of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783108" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Congenital cystic adenomatoid malformation in the fetus: natural history and predictors of outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18634115" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cystic lung lesions - prenatal diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18956429" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Prenatal diagnosis and outcome of echogenic fetal lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25805010" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Vanishing fetal lung malformations: Prenatal sonographic characteristics and postnatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12677563" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Management of asymptomatic neonatal cystic adenomatoid malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15937824" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Postnatal spontaneous resolution of congenital cystic adenomatoid malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17270558" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3903097" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Fetal cystic adenomatoid malformation: prenatal diagnosis and natural history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9790364" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Fetal lung lesions: management and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11877643" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7443311" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Congenital adenomatoid malformation of the lung. A report of 17 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24777224" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Neonatal outcomes of prenatally diagnosed congenital pulmonary malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35431039" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The natural history of prenatally diagnosed congenital pulmonary airway malformations and bronchopulmonary sequestrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12101503" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Spontaneous pneumothorax resulting from congenital cystic adenomatoid malformation in a pre-term infant: case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6718709" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Late presentation of congenital cystic adenomatoid malformation of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16200619" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Congenital cystic lung lesions: is surgical resection essential?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11961429" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Late-onset congenital cystic adenomatoid malformation of the lung. Embryology, clinical symptomatology, diagnostic procedures, therapeutic approach and clinical follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31238368" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Lung Ultrasound: A New Tool in the Management of Congenital Lung Malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10405718" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Congenital chest lesions: diagnosis and characterization with prenatal MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8497595" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cysts and cystlike lesions of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8976918" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Congenital cystic adenomatoid malformation of the lung: CT-pathologic correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35771571" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Accuracy of Chest Computed Tomography in Distinguishing Cystic Pleuropulmonary Blastoma From Benign Congenital Lung Malformations in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29343557" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26925222" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9247218" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Cystic lung lesions with systemic arterial blood supply: a hybrid of congenital cystic adenomatoid malformation and bronchopulmonary sequestration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10441623" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Extralobar sequestration with frequently associated congenital cystic adenomatoid malformation, type 2: report of 50 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36328607" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Management of Congenital Lung Malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9021566" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Congenital malformations of the lung and mediastinum--a quarter century of experience from a single institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10661844" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Congenital cystic disease of the lung in infants and children (experience with 57 cases).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15621470" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Congenital lung malformations--antenatal and postnatal evaluation and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692922" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Results of surgical treatment of congenital cystic lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16581208" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Management of congenital lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22498375" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Is radical lobectomy required in congenital cystic adenomatoid malformation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37391296" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Sublobar Pulmonary Resection in Children With Congenital Lung Abnormalities: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051051" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The argument for a non-operative approach to asymptomatic lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051052" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The argument for operative approach to asymptomatic lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28709163" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Current Management of Congenital Pulmonary Airway Malformations: A "European Pediatric Surgeons' Association" Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36010044" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The Management of Asymptomatic Congenital Pulmonary Airway Malformation: Results of a European Delphi Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9314270" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Embryonal rhabdomyosarcoma of the lung arising in cystic adenomatoid malformation: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1403524" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Rhabdomyosarcoma arising within congenital pulmonary cysts: report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2235763" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Malignant mesenchymoma associated with a congenital lung cyst in a child: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26775193" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22595560" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Does earlier lobectomy result in better long-term pulmonary function in children with congenital lung anomalies? A prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28951013" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Long-term lung function in children following lobectomy for congenital lung malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28584070" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The natural history of prenatally diagnosed congenital cystic lung lesions: long-term follow-up of 119 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30009482" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Prenatally diagnosed congenital lung malformations-A long-term outcome study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16131533" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Outcome of antenatally suspected congenital cystic adenomatoid malformation of the lung: 10 years' experience 1991-2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28293700" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Optimal age for elective surgery of asymptomatic congenital pulmonary airway malformation: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29514740" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Optimal timing for elective resection of asymptomatic congenital pulmonary airway malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17270559" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Antenatally suspected congenital cystic adenomatoid malformation of the lung: postnatal investigation and timing of surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15770585" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Asymptomatic congenital lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29108843" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Outcomes following elective resection of congenital pulmonary airway malformations are equivalent after 3 months of age and a weight of 5 kg.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23395142" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Management of prenatally diagnosed lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16677877" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Perinatal management of congenital cystic lung lesions in the age of minimally invasive surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12677564" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Thoracoscopic lobectomy for prenatally diagnosed lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18206452" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Thoracoscopic versus open resection for congenital cystic adenomatoid malformations of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22595561" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Thoracoscopic vs open resection of congenital lung lesions: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24315887" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Thoracoscopic vs open lobectomy in infants and young children with congenital lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10706518" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Haemopneumothorax from congenital cystic adenomatoid malformation in a cryptorchidism patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15017547" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Perinatally diagnosed asymptomatic congenital cystic adenomatoid malformation: to resect or not?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17056845" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : CAM lungs: the conservative approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24406806" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Conservative management of antenatally diagnosed cystic lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19404649" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Long-term outcome of asymptomatic patients with congenital cystic adenomatoid malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27423390" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9475333" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Bronchioloalveolar carcinoma arising in congenital cystic adenomatoid malformation in a child: a case report and review on malignancies originating in congenital cystic adenomatoid malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11431779" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Primary pulmonary rhabdomyosarcoma arising within cystic adenomatoid malformation: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16856157" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Correction: Pleuropulmonary blastoma, not rhabdomyosarcoma in a congenital lung cyst.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20620300" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Is congenital cystic adenomatoid malformation a premalignant lesion for pleuropulmonary blastoma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33762310" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Pleuropulmonary Blastoma in Pediatric Lung Lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31277979" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Diagnosis and treatment of pleuropulmonary blastoma in children: A single-center report of 41 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26561249" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19556464" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : DICER1 mutations in familial pleuropulmonary blastoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051053" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Adult lung tumours of childhood origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30715996" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28323992" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27441995" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Macrocephaly associated with the DICER1 syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12883247" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11475118" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Pleuropulmonary blastoma in congenital cystic adenomatoid malformation: report of a case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12520470" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : New concepts in the pathology of congenital lung malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17527088" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34980466" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Neonatal congenital pulmonary airway malformation associated with mucinous adenocarcinoma and KRAS mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15065026" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Current outcome of antenally diagnosed cystic lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18330859" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Postnatal management and outcome of prenatally diagnosed lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11120908" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Adult outcome of congenital lower respiratory tract malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21616235" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : A contemporary evaluation of pulmonary function in children undergoing lung resection in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23108035" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Lung function of infants with congenital lung lesions in the first year of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28737279" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Exercise capacity is not decreased in children who have undergone lung resection early in life for congenital thoracic malformations compared to healthy age-matched children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31012287" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Lung function, exercise tolerance, and physical growth of children with congenital lung malformations at 8 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36553325" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Congenital Lung Malformations: Clinical and Functional Respiratory Outcomes after Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11316935" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10415279" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Cystic adenomatoid malformation of the lung: neonatal management of 21 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8449065" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Congenital cystic adenomatoid malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1552445" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Persistent pulmonary hypertension complicating cystic adenomatoid malformation in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9561965" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Successful perioperative management of congenital cystic adenomatoid malformation of the lung by high frequency oscillatory ventilation--report of two cases.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
